Nucleus Network begins dosing for third COVID-19 vaccine trial
1 September 2020 Australia’s largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial COVID-19 Vaccine trial in collaboration with the vaccine’s developer Serum Institute of India…
Living with COVID-19 – an assessment of the pandemic’s ongoing impact on Australian Healthcare (IQVIA)
Date posted 1 September 2020 IQVIA ANZ business has just released; Living with COVID-19 – an assessment of the pandemic’s ongoing impact on Australian Healthcare. This is the second in a special series of reports, which offer IQVIA’s…
Luina Bio announces new Bio-manufacturing GMP and development facility expansion
1 September 2020 Highlights Small scale GMP manufacturing suites open in Q3 2020 500L tech transfer and process development site aim for open Q4 2020 This precedes the next phase with Luina planning to commission a 10,000m2 late…
4DMedical Release FY20 Full Year Results
1 September 2020 Release date 28 August 2020 4DMedical Limited, a medical technology company focused on commercialising its patented respiratory imaging technology, today announces its full year results for the financial year ended 30 June 2020 (FY20). During…
Burnet Institute: Focus on milestones, not time frames for COVID exit
31 August 2020 Burnet Director and CEO Professor Brendan Crabb AC believes Victoria’s exit strategy from stage four COVID-19 restrictions should be measured in terms of milestones, not time frames – and the key benchmark is the elimination…
Exopharm Raises $10m in Well Supported Placement
31 August 2020 Release date 27 August 2020 Exopharm to place 41,666,667 shares at $0.24 per share to institutional and high net worth investors to raise $10m before costs Shares to be issued in two tranches with tranche…
St Vincent’s Hospital on the Park leads new charge in Victoria’s collective fight against COVID-19
31 August 2020 Release date 26 August 2020 St Vincent’s has welcomed patients at its newest hospital to help manage the escalating demand on Victoria’s healthcare system caused by the COVID-19 pandemic. The Victorian Government called on St…
Lessons from the COVID-19 frontline captured in UniMelb Health Worker Voices project
31 August 2020 Release date 24 August 2020 Voice memos from health workers in Australia and around the world are being collected via a private WhatsApp chat to capture their experience of the coronavirus (COVID-19) pandemic and improve…
Immutep and Monash University Receive Grant Funding for LAG-3 Project
31 August 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to announce that the Australian Research Council (ARC) has awarded Immutep and research partner Monash University a A$671,427 grant under the ARC‘s Linkage Project scheme to…
Patient Enrolment Opens in Cynata COVID-19 Clinical Trial
31 August 2020 Release date 24 August 2020 Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the MEND (MEseNchymal coviD-19) Trial is now open for patient enrolment.…
Search for COVID-19 drugs boosted by SARS discovery
26 August 2020 An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19. Using the National Drug Discovery Centre, researchers from the Walter and…
World Mosquito Program’s Wolbachia method dramatically reduces dengue incidence in randomised controlled trial in Indonesia
26 August 2020 The World Mosquito Program (WMP) of Monash University, and its Indonesian partners the Tahija Foundation and Universitas Gadjah Mada have announced the first results of a cluster randomised controlled trial of its Wolbachia method ,…
